Ra Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
RARX
CUSIP
74933V108
All holders as of
Q2 2020
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2020 Q2 1 266 $32.0 k
2020 Q1 168 51.4 M $2.47 B
2019 Q4 171 50.5 M $2.37 B
2019 Q3 125 48.4 M $1.15 B
2019 Q2 128 43.1 M $1.29 B
2019 Q1 127 40.2 M $900 M
2018 Q4 96 38.3 M $642 M
2018 Q3 73 24.6 M $445 M
2018 Q2 63 23.5 M $234 M
2018 Q1 77 24.6 M $131 M
2017 Q4 66 15.4 M $131 M
2017 Q3 64 15.8 M $230 M
2017 Q2 65 15.0 M $281 M
2017 Q1 62 14.0 M $297 M
2016 Q4 60 14.1 M $215 M